Your browser doesn't support javascript.
loading
HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy.
Salman, Shaima; Meyers, David J; Wicks, Elizabeth E; Lee, Sophia N; Datan, Emmanuel; Thomas, Aline M; Anders, Nicole M; Hwang, Yousang; Lyu, Yajing; Yang, Yongkang; Jackson, Walter; Dordai, Dominic; Rudek, Michelle A; Semenza, Gregg L.
Afiliación
  • Salman S; Armstrong Oxygen Biology Research Center.
  • Meyers DJ; Institute for Cell Engineering.
  • Wicks EE; McKusick-Nathans Department of Genetic Medicine.
  • Lee SN; Department of Pharmacology and Molecular Sciences.
  • Datan E; Armstrong Oxygen Biology Research Center.
  • Thomas AM; Institute for Cell Engineering.
  • Anders NM; Armstrong Oxygen Biology Research Center.
  • Hwang Y; Institute for Cell Engineering.
  • Lyu Y; Armstrong Oxygen Biology Research Center.
  • Yang Y; Institute for Cell Engineering.
  • Jackson W; McKusick-Nathans Department of Genetic Medicine.
  • Dordai D; Institute for Cell Engineering.
  • Rudek MA; Department of Radiology and Radiological Science.
  • Semenza GL; Department of Oncology and Sidney Kimmel Comprehensive Cancer Center.
J Clin Invest ; 132(9)2022 05 02.
Article en En | MEDLINE | ID: mdl-35499076
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Animals / Humans Idioma: En Revista: J Clin Invest Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Animals / Humans Idioma: En Revista: J Clin Invest Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos